A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia

Clinical trial NCT01345708 · COMPLETED

Trial details

NCT number: NCT01345708
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autoimmune Hemolytic Disease (Cold Type) (Warm Type)

Start date: 2009-01-01
Primary completion: 2010-01-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.